ARTICLE | Company News
Europroteome diagnostic news
August 23, 2004 7:00 AM UTC
Europroteome, which develops serum-based diagnostics and compounds targeting membrane proteins for cancer, has filed for insolvency. The company said it is in negotiations with potential buyers to sel...